New Trial: Psilocybin Administration With 5-HT1a Blockade

Trial Overview

NCT ID: NCT07565493 Phase: EARLY_PHASE1 Enrollment Target: 18 Status: Recruiting

The purpose of this study is to assess the effects of 5-HT1A receptor blockade on the acute subjective effects of psilocybin, as measured through subjective survey measures and acute electroencephalography (EEG). Further, the investigators will assess the effects of psilocybin on post-acute sleep and dreaming through the use of sleep EEG and sleep and dream diaries.

Why This Matters

[Draft — editorial context needed]

Source

• View full trial on ClinicalTrials.gov